Evidence map›Paper›PMID 38267694›Full record

ArticleCellular & molecular immunology2024

Disulfiram ameliorates STING/MITA-dependent inflammation and autoimmunity by targeting RNF115.

Zhi-Dong Zhang, Chang-Rui Shi, Fang-Xu Li, Hu Gan, Yanhong Wei, Qianhui Zhang, Xin Shuai, Min Chen, Yu-Lin Lin, Tian-Chen Xiong and 3 more

Open access · greenAbstract read
In one paragraph

Article in Cellular & molecular immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. The mouse resource at National Resource Center for Mutant Mice of China.Mammalian genome : official journal of the International Mammalian Genome Society · 2025
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Zhi-Dong ZhangDepartment of Gastrointestinal Surgery, Medical Research Institute, Frontier Science Center of Immunology and Metabolism, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, 430071, China.ORCID 0000-0003-4892-9129
Chang-Rui ShiDepartment of Gastrointestinal Surgery, Medical Research Institute, Frontier Science Center of Immunology and Metabolism, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, 430071, China.
Fang-Xu LiDepartment of Gastrointestinal Surgery, Medical Research Institute, Frontier Science Center of Immunology and Metabolism, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, 430071, China.
Hu GanDepartment of Gastrointestinal Surgery, Medical Research Institute, Frontier Science Center of Immunology and Metabolism, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, 430071, China.
Yanhong WeiDepartment of Rheumatology and Immunology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
Qianhui ZhangDepartment of Rheumatology and Immunology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
Xin ShuaiDepartment of Gastrointestinal Surgery, Medical Research Institute, Frontier Science Center of Immunology and Metabolism, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, 430071, China.
Min ChenDepartment of Rheumatology and Immunology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
Yu-Lin LinDepartment of Gastrointestinal Surgery, Medical Research Institute, Frontier Science Center of Immunology and Metabolism, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, 430071, China.
Tian-Chen XiongDepartment of Gastrointestinal Surgery, Medical Research Institute, Frontier Science Center of Immunology and Metabolism, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, 430071, China.
Xiaoqi ChenDepartment of Rheumatology and Immunology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China. xiaoqichen_whu@163.com.
Bo ZhongDepartment of Gastrointestinal Surgery, Medical Research Institute, Frontier Science Center of Immunology and Metabolism, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, 430071, China. zhongbo@whu.edu.cn.ORCID 0000-0002-3832-2895
Dandan LinCancer Center, Renmin Hospital of Wuhan University, Wuhan, 430060, China. lindandan@whu.edu.cn.
Wuhan University · CN

Funding

National Natural Science Foundation of China (National Science Foundation of China) 31930040National Natural Science Foundation of China (National Science Foundation of China) 823B1006
6 · The paper itself

Abstract

STING (also known as MITA) is an adaptor protein that mediates cytoplasmic DNA-triggered signaling, and aberrant activation of STING/MITA by cytosolic self-DNA or gain-of-function mutations causes severe inflammation. Here, we show that STING-mediated inflammation and autoimmunity are promoted by RNF115 and alleviated by the RNF115 inhibitor disulfiram (DSF). Knockout of RNF115 or treatment with DSF significantly inhibit systemic inflammation and autoimmune lethality and restore immune cell development in Trex1

Indexed as

Autoimmune DiseasesAutoimmunityAnimalsCytokinesDisulfiramDNAEndothelial CellsHumansInflammationMiceMice, KnockoutUbiquitin-Protein LigasesCytokinesDisulfiramDNARNF115 protein, humanUbiquitin-Protein LigasesAutoimmunityDisulfiramRNF115SLESTING/MITA

Identifiers

PMID38267694
PMCPMC10901794
OpenAlexW4391173549

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.